Pancreatic Cancer has a single digit survival rate of just 7 percent after five years; this must change and federally funded cancer research is a necessary tool for the change. I would like to take this opportunity to thank Sen. Mike Crapo, Sen. Jim Risch and Rep. Mike Simpson for their continued support of vital cancer research funding for the National Institutes of Health and the Department of Defense’s Peer-Reviewed Cancer Research Program. While meeting with the Idaho delegation for the Pancreatic Cancer Action Network’s Advocacy Day in Washington DC on June 23, 2015, a commitment of funding support was made by these gentlemen. Also a promise by Sens. Risch and Crapo to join the Bicameral Congressional Caucus on the Deadliest Cancers. Thank you very much Rep. Simpson and Sens. Risch and Crapo for supporting the funding requests needed for cancer research; a nonpartisan life issue.
Patty Rowett-Matlock, advocacy chair, Pancreatic Cancer Action Network Boise Affiliate, Boise